Back to Directory
Insulin Inhaled (Afrezza)
Performance & EnduranceRapid-acting inhaled insulin powder for mealtime coverage without injections.
Key Benefits
- ✓No mealtime injections
- ✓Ultra-rapid onset
- ✓Fast offset
- ✓Convenient administration
- ✓Different delivery route
Dosing Information
Dosage Range
4-12 units
Frequency
With each meal
Typical Duration
Ongoing
Detailed Protocol
Inhaled at beginning of meal using special inhaler device. Dose based on carbs (4-unit, 8-unit, 12-unit cartridges). Pulmonary function testing required before and during use. Prescription only.
About Insulin Inhaled (Afrezza)
Afrezza is recombinant human insulin formulated as an inhalable powder for pulmonary delivery. Ultra-rapid onset (12-15 minutes) and offset (2-3 hours). Alternative to mealtime injections. FDA-approved.
Research Notes
FDA-approved in 2014. Ultra-rapid pharmacokinetics. Requires pulmonary function monitoring. Contraindicated in chronic lung disease. Alternative for injection-averse patients.
Potential Side Effects
- •Cough
- •Throat irritation
- •Contraindicated in lung disease
- •Pulmonary function decline
- •Hypoglycemia
- •Not for smokers
Always consult with a healthcare professional before starting any peptide therapy.